Ryan T. Evans

Associate Director Of Product Development at Biofidelity

Ryan T. Evans has extensive work experience in the field of genomics and laboratory operations. Ryan T. is currently the Associate Director of Product Development at Biofidelity, starting in September 2021. Prior to this, they held various roles at Q2 Solutions, including Associate Director of Clinical Testing and Manager of Targeted Sequencing & Emerging Technologies. At Q2 Solutions, they were responsible for overseeing laboratory operations for genomics assays, managing project resources and timelines, and strengthening customer relationships through technical consultation. Ryan has also worked as an Adjunct Instructor at the University of North Carolina at Chapel Hill School of Medicine, a Laboratory Specialist at the University of North Carolina at Chapel Hill, and an Analytical Chemist at Pfizer Contractor, Atlas Data Systems. Ryan T. has research experience as a Research Fellow at the University of Michigan's Molecular & Behavioral Neuroscience Institute and as a Graduate Student Research Associate at the University of Michigan. Ryan's early experiences include being an Undergraduate Teaching Assistant and Tutor at Lafayette College and various roles at the University of Michigan, including Graduate Student Research Associate, Advisor to Undergraduate Research Assistants, and Graduate Student Instructor.

Ryan T. Evans holds a Master's degree in Molecular Diagnostic Science from the University of North Carolina at Chapel Hill, which they obtained from 2012 to 2014. Prior to that, they pursued their Ph.D in Biological Chemistry at the University of Michigan from 2005 to 2011. Ryan began their educational journey at Lafayette College, where they earned their Bachelor of Science degree in Biochemistry, completing their studies from 2001 to 2005.

Links

Previous companies

Q2 SOLUTIONS logo
University of North Carolina at Chapel Hill logo
Pfizer logo
Lafayette College logo

Timeline

  • Associate Director Of Product Development

    September, 2021 - present

View in org chart